Design and in vitro evaluation of haloperidol transdermal patches containing PVA-Povidone as film formers
Basavaraj hulkoti, Y. Anand Kumar1, Uma A. Patil and B.M. Dinesh
1K. L. E. Society’s College of Pharmacy, 2ndblock Rajajinagar, Bangalore - 560 010 (India) 2V.L.College of Pharmacy, Raichur (India)
ABSTRACT: Matrix type TDDS of haloperidol were prepared using different ratios of Poly vinyl alcohol (PVA): Poly vinylpyrrolidone (PVP) (3:1, 2:3, 4:1, 1:2, 2:1, and 1:4) by solvent evaporation technique. Physicochemical parameters were characterized and dissolution studies of the formulated films were performed. In addition solubility studies at various pH, partition coefficient in octanol/water system, flux and enhancement ratio were also evaluated. In vitro permeation studies were done using modified Franz diffusion cells through human cadaver skin utilizing 20%PEG 400 in normal saline. Permeation studies illustrated, 4% hyaluronidase enzyme was a good enhancer. The prepared films were subjected to SEM and FTIR spectral analysis. Higuchi and Peppas model were used for optimizing the formulation.
KEYWORDS: Haloperidol ; Transdermal Patches; PVP; PVA
Download this article as:Copy the following to cite this article: Hulkoti B, Kumar Y. A, Patil U. A, Dinesh B. M. Design and in vitro evaluation of haloperidol transdermal patches containing PVA-Povidone as film formers. Biosci Biotechnol Res Asia 2007;4(2) |
Copy the following to cite this URL: Hulkoti B, Kumar Y. A, Patil U. A, Dinesh B. M. Design and in vitro evaluation of haloperidol transdermal patches containing PVA-Povidone as film formers. Biosci Biotechnol Res Asia 2007;4(2). Available from: https://www.biotech-asia.org/?p=5955 |